1 Introduction to Research & Analysis Reports
    1.1 Prescription Dermatology Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Prescription Dermatology Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Prescription Dermatology Therapeutics Overall Market Size
    2.1 Global Prescription Dermatology Therapeutics Market Size: 2021 VS 2027
    2.2 Global Prescription Dermatology Therapeutics Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Prescription Dermatology Therapeutics Players in Global Market
    3.2 Top Global Prescription Dermatology Therapeutics Companies Ranked by Revenue
    3.3 Global Prescription Dermatology Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Prescription Dermatology Therapeutics Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Prescription Dermatology Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Prescription Dermatology Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Prescription Dermatology Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Prescription Dermatology Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Prescription Dermatology Therapeutics Market Size Markets, 2021 & 2027
        4.1.2 Fungal Infection Drugs
        4.1.3 Skin Cancer Drugs
        4.1.4 Acne & Rosacea Drugs
        4.1.5 Psoriasis Drugs
        4.1.6 Dermatitis & Seborrhea Drugs
    4.2 By Type - Global Prescription Dermatology Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Prescription Dermatology Therapeutics Revenue, 2016-2021
        4.2.2 By Type - Global Prescription Dermatology Therapeutics Revenue, 2022-2027
        4.2.3 By Type - Global Prescription Dermatology Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Prescription Dermatology Therapeutics Market Size, 2021 & 2027
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Prescription Dermatology Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Prescription Dermatology Therapeutics Revenue, 2016-2021
        5.2.2 By Application - Global Prescription Dermatology Therapeutics Revenue, 2022-2027
        5.2.3 By Application - Global Prescription Dermatology Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Prescription Dermatology Therapeutics Market Size, 2021 & 2027
    6.2 By Region - Global Prescription Dermatology Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Prescription Dermatology Therapeutics Revenue, 2016-2021
        6.2.2 By Region - Global Prescription Dermatology Therapeutics Revenue, 2022-2027
        6.2.3 By Region - Global Prescription Dermatology Therapeutics Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Prescription Dermatology Therapeutics Revenue, 2016-2027
        6.3.2 US Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.3.3 Canada Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.3.4 Mexico Prescription Dermatology Therapeutics Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Prescription Dermatology Therapeutics Revenue, 2016-2027
        6.4.2 Germany Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.4.3 France Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.4.4 U.K. Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.4.5 Italy Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.4.6 Russia Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.4.7 Nordic Countries Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.4.8 Benelux Prescription Dermatology Therapeutics Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Prescription Dermatology Therapeutics Revenue, 2016-2027
        6.5.2 China Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.5.3 Japan Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.5.4 South Korea Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.5.5 Southeast Asia Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.5.6 India Prescription Dermatology Therapeutics Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Prescription Dermatology Therapeutics Revenue, 2016-2027
        6.6.2 Brazil Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.6.3 Argentina Prescription Dermatology Therapeutics Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Prescription Dermatology Therapeutics Revenue, 2016-2027
        6.7.2 Turkey Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.7.3 Israel Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.7.4 Saudi Arabia Prescription Dermatology Therapeutics Market Size, 2016-2027
        6.7.5 UAE Prescription Dermatology Therapeutics Market Size, 2016-2027
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Prescription Dermatology Therapeutics Major Product Offerings
        7.1.4 Pfizer Prescription Dermatology Therapeutics Revenue in Global (2016-2021)
        7.1.5 Pfizer Key News
    7.2 AbbVie
        7.2.1 AbbVie Corporate Summary
        7.2.2 AbbVie Business Overview
        7.2.3 AbbVie Prescription Dermatology Therapeutics Major Product Offerings
        7.2.4 AbbVie Prescription Dermatology Therapeutics Revenue in Global (2016-2021)
        7.2.5 AbbVie Key News
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Corporate Summary
        7.3.2 Johnson & Johnson Business Overview
        7.3.3 Johnson & Johnson Prescription Dermatology Therapeutics Major Product Offerings
        7.3.4 Johnson & Johnson Prescription Dermatology Therapeutics Revenue in Global (2016-2021)
        7.3.5 Johnson & Johnson Key News
    7.4 Novartis
        7.4.1 Novartis Corporate Summary
        7.4.2 Novartis Business Overview
        7.4.3 Novartis Prescription Dermatology Therapeutics Major Product Offerings
        7.4.4 Novartis Prescription Dermatology Therapeutics Revenue in Global (2016-2021)
        7.4.5 Novartis Key News
    7.5 Amgen
        7.5.1 Amgen Corporate Summary
        7.5.2 Amgen Business Overview
        7.5.3 Amgen Prescription Dermatology Therapeutics Major Product Offerings
        7.5.4 Amgen Prescription Dermatology Therapeutics Revenue in Global (2016-2021)
        7.5.5 Amgen Key News
    7.6 Eli Lilly
        7.6.1 Eli Lilly Corporate Summary
        7.6.2 Eli Lilly Business Overview
        7.6.3 Eli Lilly Prescription Dermatology Therapeutics Major Product Offerings
        7.6.4 Eli Lilly Prescription Dermatology Therapeutics Revenue in Global (2016-2021)
        7.6.5 Eli Lilly Key News
    7.7 Celgene
        7.7.1 Celgene Corporate Summary
        7.7.2 Celgene Business Overview
        7.7.3 Celgene Prescription Dermatology Therapeutics Major Product Offerings
        7.4.4 Celgene Prescription Dermatology Therapeutics Revenue in Global (2016-2021)
        7.7.5 Celgene Key News
    7.8 LEO Pharma
        7.8.1 LEO Pharma Corporate Summary
        7.8.2 LEO Pharma Business Overview
        7.8.3 LEO Pharma Prescription Dermatology Therapeutics Major Product Offerings
        7.8.4 LEO Pharma Prescription Dermatology Therapeutics Revenue in Global (2016-2021)
        7.8.5 LEO Pharma Key News
    7.9 Bausch Health Companies
        7.9.1 Bausch Health Companies Corporate Summary
        7.9.2 Bausch Health Companies Business Overview
        7.9.3 Bausch Health Companies Prescription Dermatology Therapeutics Major Product Offerings
        7.9.4 Bausch Health Companies Prescription Dermatology Therapeutics Revenue in Global (2016-2021)
        7.9.5 Bausch Health Companies Key News
    7.10 Sun Pharmaceutical
        7.10.1 Sun Pharmaceutical Corporate Summary
        7.10.2 Sun Pharmaceutical Business Overview
        7.10.3 Sun Pharmaceutical Prescription Dermatology Therapeutics Major Product Offerings
        7.10.4 Sun Pharmaceutical Prescription Dermatology Therapeutics Revenue in Global (2016-2021)
        7.10.5 Sun Pharmaceutical Key News
    7.11 Aclaris Therapeutics
        7.11.1 Aclaris Therapeutics Corporate Summary
        7.11.2 Aclaris Therapeutics Business Overview
        7.11.3 Aclaris Therapeutics Prescription Dermatology Therapeutics Major Product Offerings
        7.11.4 Aclaris Therapeutics Prescription Dermatology Therapeutics Revenue in Global (2016-2021)
        7.11.5 Aclaris Therapeutics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer